Welcome to the Clarivate news hub

Clarivate Plc to Change NYSE Ticker Symbol to “CLVT” on February 1, 2021

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content

Complete insights on biologic CMC requirements enable pharma, biotech and generics organizations accelerate innovation by bringing life-saving medicines to patients faster

Clarivate Announces Change to Board of Directors

Clarivate to Report Fourth Quarter and Full Year 2020 Results on February 25, 2021

Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China Release Annual Joint Report to Identify 100+ Engineering Fronts

New Clarivate Report Reveals Mainland China as Prominent Innovator in the Global Alcoholic Beverage Industry

India Reinforces Position as Innovation Hub in South and South East Asia, Says New Clarivate Report

Clarivate to Present at the Barclays Global Technology, Media and Telecommunications Conference on December 9, 2020

Clarivate Awards Restricted Share Units to Global Workforce

Hanlim IPS Joins Clarivate

Clarivate Announces it 2021 Adjusted Earnings Per Share Outlook

Clarivate Pledges Support for the Women’s Empowerment Principles

New Centre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials

Clarivate Strengthens IP Offering in Mainland China with New Domain Registrar License

Clarivate Recognizes Most Influential Innovators at South and South East Asia Innovation Forum